Post covid-19 invasive pulmonary Aspergillosis: A case report

• Published in: International journal of surgery case reports 2021-05, Vol.82, p.105865, Article 105865
• Main Authors: Kakamad, Fahmi H., Mahmood, Safeen O., Rahim, Hawbash M., Abdulla, Berwn A., Abdullah, Hiwa O., Othman, Snur, Mohammed, Shvan H., Kakamad, Suhaib H., Mustafa, Shevan M., Salih, Abdulwahid M.
• Format: Article
• Language: English
• Subjects: CAPA; Case Report; Complications; COVID-19; Fungal infection
• ISSN: 2210-2612; 2210-2612
• DOI: 10.1016/j.ijscr.2021.105865

•Several complications after corona viral infection-19 (COVID-19) have been reported.•Some of these complications may require surgical intervention.•Aspergillosis is one of the COVID-19 complications.•In this study a case with post-COGID-19 pulmonary fungal infection is discussed. Several complications after corona viral infection-19 (COVID-19) have been reported. The study aims is to present a case with post-covid-19 pulmonary fungal infection with antifungal resistance characteristics. A 50-year-old male presented with hemoptysis, dyspnea, cough, fever, and rigor for 4-month duration. Three weeks before this complaint, he had cured of COVID-19. Investigations showed multiple ill-defined cavitary lesions involving the left upper lobe. The patient underwent a left upper lobectomy. The post-operative period was uneventful. All studies of COVID-19 fungal infections reported occurrence during the COVID-19 infection, mostly 14 days after the appearance of COVID-19 symptoms. The case in the current study was a 50-year-old patient, who was previously diagnosed with COVID-19 for a period of 4 months. After a few days from his recovery, the patient developed dyspnea, cough, fever, and rigor again. Pulmonary aspergillosis is a serious complication of COVID-19 patients that may not respond well to medical therapy. Pulmonary resection is the last and effective strategy to control the disease.